182 related articles for article (PubMed ID: 29378276)
1. Biological macromolecules for ophthalmic drug delivery to treat ocular diseases.
Krishnaswami V; Kandasamy R; Alagarsamy S; Palanisamy R; Natesan S
Int J Biol Macromol; 2018 Apr; 110():7-16. PubMed ID: 29378276
[TBL] [Abstract][Full Text] [Related]
2. Overview of biopolymers as carriers of antiphlogistic agents for treatment of diverse ocular inflammations.
Sharma AK; Arya A; Sahoo PK; Majumdar DK
Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():779-791. PubMed ID: 27287177
[TBL] [Abstract][Full Text] [Related]
3. Polymer-based carriers for ophthalmic drug delivery.
Imperiale JC; Acosta GB; Sosnik A
J Control Release; 2018 Sep; 285():106-141. PubMed ID: 29964135
[TBL] [Abstract][Full Text] [Related]
4. Nanotherapies for the treatment of ocular diseases.
Reimondez-Troitiño S; Csaba N; Alonso MJ; de la Fuente M
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):279-93. PubMed ID: 25725262
[TBL] [Abstract][Full Text] [Related]
5. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
Li J; Tan G; Cheng B; Liu D; Pan W
Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in ocular drug delivery.
Achouri D; Alhanout K; Piccerelle P; Andrieu V
Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
[TBL] [Abstract][Full Text] [Related]
7. A New Direction in Ophthalmic Development: Nanoparticle Drug Delivery Systems.
Andonova VY
Curr Pharm Des; 2016; 22(41):6313-6329. PubMed ID: 27526789
[TBL] [Abstract][Full Text] [Related]
8. Advances in ocular drug delivery.
Rawas-Qalaji M; Williams CA
Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive review on contact lens for ophthalmic drug delivery.
Xu J; Xue Y; Hu G; Lin T; Gou J; Yin T; He H; Zhang Y; Tang X
J Control Release; 2018 Jul; 281():97-118. PubMed ID: 29782944
[TBL] [Abstract][Full Text] [Related]
10. Chitosan nanoparticles for drug delivery to the eye.
Paolicelli P; de la Fuente M; Sánchez A; Seijo B; Alonso MJ
Expert Opin Drug Deliv; 2009 Mar; 6(3):239-53. PubMed ID: 19290841
[TBL] [Abstract][Full Text] [Related]
11. Protein delivery to the back of the eye: barriers, carriers and stability of anti-VEGF proteins.
Radhakrishnan K; Sonali N; Moreno M; Nirmal J; Fernandez AA; Venkatraman S; Agrawal R
Drug Discov Today; 2017 Feb; 22(2):416-423. PubMed ID: 27818255
[TBL] [Abstract][Full Text] [Related]
12. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; du Toit LC
J Pharm Sci; 2010 May; 99(5):2219-39. PubMed ID: 19894268
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional properties of organic-inorganic hybrid nanocomposites based on chitosan derivatives and layered double hydroxides for ocular drug delivery.
Xu T; Zhang J; Chi H; Cao F
Acta Biomater; 2016 May; 36():152-63. PubMed ID: 26940970
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in Topical Ocular Drug Delivery.
Yellepeddi VK; Palakurthi S
J Ocul Pharmacol Ther; 2016 Mar; 32(2):67-82. PubMed ID: 26666398
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.
Souto EB; Doktorovova S; Gonzalez-Mira E; Egea MA; Garcia ML
Curr Eye Res; 2010 Jul; 35(7):537-52. PubMed ID: 20597640
[TBL] [Abstract][Full Text] [Related]
16. Ophthalmic nano-bioconjugates: critical challenges and technological advances.
Sanap SN; Bisen AC; Agrawal S; Kedar A; Bhatta RS
Ther Deliv; 2023 Jul; 14(7):419-441. PubMed ID: 37535389
[TBL] [Abstract][Full Text] [Related]
17. Contact lenses: promising devices for ocular drug delivery.
Guzman-Aranguez A; Colligris B; Pintor J
J Ocul Pharmacol Ther; 2013 Mar; 29(2):189-99. PubMed ID: 23215541
[TBL] [Abstract][Full Text] [Related]
18. Vesicular systems in ocular drug delivery: an overview.
Kaur IP; Garg A; Singla AK; Aggarwal D
Int J Pharm; 2004 Jan; 269(1):1-14. PubMed ID: 14698571
[TBL] [Abstract][Full Text] [Related]
19. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
Jiao J
Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195
[TBL] [Abstract][Full Text] [Related]
20. Colloidal nanosystems with mucoadhesive properties designed for ocular topical delivery.
Silva B; São Braz B; Delgado E; Gonçalves L
Int J Pharm; 2021 Sep; 606():120873. PubMed ID: 34246741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
